^OEX vs. LLY

Last updated Apr 2, 2026

Compare and contrast key facts about S&P 100 Index (^OEX) and Eli Lilly and Company (LLY).

Performance

^OEX vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in S&P 100 Index (^OEX) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

^OEX vs. LLY - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
^OEX S&P 100 Index	-6.49%	18.76%	29.25%	30.83%	-22.12%	27.55%	19.30%	29.47%	-5.86%	19.34%
LLY Eli Lilly and Company	-11.03%	40.25%	33.30%	60.91%	34.26%	66.08%	31.04%	16.14%	40.45%	17.83%

Returns By Period

In the year-to-date period, ^OEX achieves a -6.49% return, which is significantly higher than LLY's -11.03% return. Over the past 10 years, ^OEX has underperformed LLY with an annualized return of 13.32%, while LLY has yielded a comparatively higher 31.41% annualized return.

^OEX

• 1D: 0.73%
• 1M: -4.22%
• YTD: -6.49%
• 6M: -4.06%
• 1Y: 17.96%
• 3Y*: 19.64%
• 5Y*: 11.98%
• 10Y*: 13.32%

LLY

• 1D: 3.78%
• 1M: -6.23%
• YTD: -11.03%
• 6M: 16.00%
• 1Y: 19.42%
• 3Y*: 41.64%
• 5Y*: 40.20%
• 10Y*: 31.41%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

^OEX vs. LLY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

^OEX

^OEX Risk / Return Rank: 67
^OEX Sharpe Ratio Rank: 64
^OEX Sortino Ratio Rank: 66
^OEX Omega Ratio Rank: 70
^OEX Calmar Ratio Rank: 66
^OEX Martin Ratio Rank: 69

LLY

LLY Risk / Return Rank: 54
LLY Sharpe Ratio Rank: 57
LLY Sortino Ratio Rank: 52
LLY Omega Ratio Rank: 53
LLY Calmar Ratio Rank: 54
LLY Martin Ratio Rank: 54

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

^OEX vs. LLY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for S&P 100 Index (^OEX) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	^OEX	LLY	Difference
Sharpe ratio Return per unit of total volatility	0.93	0.46	+0.47
Sortino ratio Return per unit of downside risk	1.46	0.90	+0.55
Omega ratio Gain probability vs. loss probability	1.22	1.13	+0.09
Calmar ratio Return relative to maximum drawdown	1.53	0.54	+0.98
Martin ratio Return relative to average drawdown	5.98	1.33	+4.65
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

^OEX vs. LLY - Sharpe Ratio Comparison

The current ^OEX Sharpe Ratio is 0.93, which is higher than the LLY Sharpe Ratio of 0.46. The chart below compares the historical Sharpe Ratios of ^OEX and LLY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	^OEX	LLY	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.93	0.46	+0.47
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.68	1.26	-0.58
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.72	1.06	-0.33
Sharpe Ratio (All Time) Calculated using the full available price history	0.49	0.57	-0.07

Correlation

The correlation between ^OEX and LLY is 0.47, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Drawdowns

^OEX vs. LLY - Drawdown Comparison

The maximum ^OEX drawdown since its inception was -61.31%, smaller than the maximum LLY drawdown of -68.24%. Use the drawdown chart below to compare losses from any high point for ^OEX and LLY.

Drawdown Indicators

	^OEX	LLY	Difference
Max Drawdown Largest peak-to-trough decline	-61.31%	-68.24%	+6.93%
Max Drawdown (1Y) Largest decline over 1 year	-12.08%	-30.26%	+18.18%
Max Drawdown (5Y) Largest decline over 5 years	-27.23%	-34.48%	+7.25%
Max Drawdown (10Y) Largest decline over 10 years	-31.53%	-34.48%	+2.95%
Current Drawdown Current decline from peak	-7.80%	-13.86%	+6.06%
Average Drawdown Average peak-to-trough decline	-12.87%	-19.25%	+6.38%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.09%	12.39%	-9.30%

Volatility

^OEX vs. LLY - Volatility Comparison

The current volatility for S&P 100 Index (^OEX) is 5.63%, while Eli Lilly and Company (LLY) has a volatility of 9.94%. This indicates that ^OEX experiences smaller price fluctuations and is considered to be less risky than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	^OEX	LLY	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.63%	9.94%	-4.31%
Volatility (6M) Calculated over the trailing 6-month period	10.07%	26.02%	-15.95%
Volatility (1Y) Calculated over the trailing 1-year period	19.34%	42.60%	-23.26%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	17.74%	32.17%	-14.43%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	18.44%	29.82%	-11.38%